Board of Directors

Genpharm’s Board is comprised of Senior Executives from several industries including R&D, Biotech, Pharmaceutical, Financial Services, and Management. Through their Executive Board memberships on several organizations and vast management experience, they provide strategic guidance to Genpharm and its partners in MENAT.

Karim Smaira
CEO and Co-Founder
Elmar Schnee
Chairman of Calliditas Biopharmaceuticals
Samy Ashkar
Chief Scientific Officer at Saro Research
Mark Rothera
CEO of Viracta Therapeutics
Kamel Ghammachi
Chairman and Co-Founder of Genpharm

- Former Managing Director at Examon MENA
- Former Managing Director at Farbro Group
- Former General Manager at Janssen Cilag ME
- Honored by Rotary several times a Paul Harris Fellow for meeting outstanding personal, professional standards and charitable work

With over 30 years in the pharmaceutical industry, he has ample experience in bringing rare disease novel therapies to market, Kamel has held multiple Managing Director positions in several companies.

We are the first company to inroduce gene therapy into the MENA Region. The space is very promising since the region allows NPS and fast track approvals. After the FDA and or EMA approval, we are the first market to provide access to these innovative therapies. Since most diseases are pediatric and degenerative, early diagnosis, and treatment are ciritical. We are very proud to support patients in the region to improve their prognosis.